Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

A MERGER THAT MATTERS

Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter     ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness   New global agency offers 24/7 access...

Inizio

- PMLiVE

UK orders 40 million additional doses of Valneva’s COVID-19 vaccine

The UK's vaccine portfolio now includes a total of 407 million doses from a number of companies

- PMLiVE

Well-funded life sciences firms are making long-term progress – and their investors are too

This is an exciting time for British biotech and pharma, as the intense efforts to find a solution to COVID-19 offer a way out of the pandemic

- PMLiVE

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug

The drug is recommended for use in adult patients who are already receiving statin treatment

- PMLiVE

Q&A: Louise Sharp

PME interviews Makara Health's owner and managing director

- PMLiVE

Novartis, Bayer announce separate agreements to bolster COVID-19 vaccine manufacturing

Novartis will help manufacture Pfizer/BioNTech's vaccine and Bayer will do the same for CureVac's vaccine

- PMLiVE

J&J’s one-dose COVID-19 vaccine proves 66% effective in phase 3 trial

Vaccine was 57% effective against South African strain

- PMLiVE

Keeping up with the developing regulatory requirements for gene and cell therapies

By Clive Glover

- PMLiVE

Kat Arnull joins Golin London as UK group chief strategy officer

Prior to joining Golin, Arnull worked at global communications agency Freuds

- PMLiVE

EU may restrict exports of some COVID-19 vaccines

Proposed strategy follows a confrontation between the EU and AstraZeneca

Creating strong commercial relationships in a COVID world

By Lisa Alderson

- PMLiVE

The UK reasserts that the AZ vaccine is ‘effective across all age groups’

Germany's draft guidance does not recommend the vaccine for people over 65

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links